Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 480258, 11 pages
http://dx.doi.org/10.1155/2014/480258
Review Article

Antiartherosclerotic Effects of Plant Flavonoids

Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia

Received 13 November 2013; Revised 11 May 2014; Accepted 11 May 2014; Published 27 May 2014

Academic Editor: Senthil K. Venugopal

Copyright © 2014 Shamala Salvamani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Margaret, “Burden: mortality, morbidity and risk factors,” Global Status Report on Non Communicable Diseases, 2010. View at Google Scholar
  2. M. Navab, J. A. Berliner, A. D. Watson et al., “The Yin and Yang of oxidation in the development of the fatty streak,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 7, pp. 831–842, 1996. View at Google Scholar · View at Scopus
  3. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Steinberg and J. L. Witztum, Lipoproteins, Lipoprotein, Oxidation, and Atherogenesis, WB Saunders, Philadelphia, Pa, USA, 1999.
  5. J. F. Keaney Jr., “Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction,” Molecular Aspects of Medicine, vol. 21, no. 4-5, pp. 99–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Gould, J. E. Rossouw, N. C. Santanello, J. F. Heyse, and C. D. Furberg, “Cholesterol reduction yields clinical benefit: impact of statin trials,” Circulation, vol. 97, no. 10, pp. 946–952, 1998. View at Google Scholar · View at Scopus
  7. K. K. Ray and C. P. Cannon, “The potential relevance of the multiple lipid-independent (Pleiotropic) effects of statins in the management of acute coronary syndromes,” Journal of the American College of Cardiology, vol. 46, no. 8, pp. 1425–1433, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Endo, Y. Tsujita, M. Kuroda, and K. Tanzawa, “Inhibition of cholesterol synthesis in vitro and in vivo by ML 236A and ML 236B, competitive inhibitors of 3 hydroxy 3 methylglutaryl Coenzyme A reductase,” European Journal of Biochemistry, vol. 77, no. 1, pp. 31–36, 1977. View at Google Scholar · View at Scopus
  9. M. S. Brown and J. L. Goldstein, “A receptor-mediated pathway for cholesterol homeostasis,” Science, vol. 232, no. 4746, pp. 34–47, 1986. View at Google Scholar · View at Scopus
  10. D. J. Maron, G. P. Lu, N. S. Cai et al., “Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial,” Archives of Internal Medicine, vol. 163, no. 12, pp. 1448–1453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. Bradford, C. L. Shear, A. N. Chremos et al., “Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia,” Archives of Internal Medicine, vol. 151, no. 1, pp. 43–49, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. L. R. Pierce, D. K. Wysowski, and T. P. Gross, “Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy,” Journal of the American Medical Association, vol. 264, no. 1, pp. 71–75, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Agarwal and A. V. Rao, “Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study,” Lipids, vol. 33, no. 10, pp. 981–984, 1998. View at Google Scholar · View at Scopus
  14. C. Auger, P.-L. Teissedre, P. Gérain et al., “Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation,” Journal of Agricultural and Food Chemistry, vol. 53, no. 6, pp. 2015–2021, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. M. Loke, J. M. Proudfoot, J. M. Hodgson et al., “Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein e-knockout mice by alleviating inflammation and endothelial dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 749–757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Škerget, P. Kotnik, M. Hadolin, A. R. Hraš, M. Simonič, and Ž. Knez, “Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities,” Food Chemistry, vol. 89, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Sultana and F. Anwar, “Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants,” Food Chemistry, vol. 108, no. 3, pp. 879–884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. M. Ribnicky, P. Kuhn, A. Poulev et al., “Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.,” International Journal of Pharmaceutics, vol. 370, no. 1-2, pp. 87–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Patil, R. Patil, B. Ahirwar, and D. Ahirwar, “Isolation and characterization of anti-diabetic component (bioactivity-guided fractionation) from Ocimum sanctum L. (Lamiaceae) aerial part,” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 4, pp. 278–282, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wainstein, T. Ganz, M. Boaz et al., “Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats,” Journal of Medicinal Food, vol. 15, no. 7, pp. 605–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Tabassum and F. Ahmad, “Role of natural herbs in the treatment of hypertension,” Pharmacognosy Reviews, vol. 5, no. 9, pp. 30–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. I. Koo and S. K. Noh, “Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect,” Journal of Nutritional Biochemistry, vol. 18, no. 3, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. K. Singh, S. Banerjee, and T. D. Porter, “Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells,” The Journal of Nutritional Biochemistry, vol. 20, no. 10, pp. 816–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ismail, G. Al-Naqeep, and K. W. Chan, “Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats,” Free Radical Biology and Medicine, vol. 48, no. 5, pp. 664–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. C. Rhodes and K. R. Price, “Analytical problems in the study of flavonoid compounds in onions,” Food Chemistry, vol. 57, no. 1, pp. 113–117, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Dinelli, A. Bonetti, M. Minelli, I. Marotti, P. Catizone, and A. Mazzanti, “Content of flavonols in Italian bean (Phaseolus vulgaris L.) ecotypes,” Food Chemistry, vol. 99, no. 1, pp. 105–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. E. Rocha-Guzmán, A. Herzog, R. F. González-Laredo, F. J. Ibarra-Pérez, G. Zambrano-Galván, and J. A. Gallegos-Infante, “Antioxidant and antimutagenic activity of phenolic compounds in three different colour groups of common bean cultivars (Phaseolus vulgaris),” Food Chemistry, vol. 103, no. 2, pp. 521–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Havsteen, “Flavonoids, a class of natural products of high pharmacological potency,” Biochemical Pharmacology, vol. 32, no. 7, pp. 1141–1148, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. M. G. L. Hertog, D. Kromhout, C. Aravanis et al., “Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study,” Archives of Internal Medicine, vol. 155, no. 4, pp. 1184–1195, 1995. View at Google Scholar · View at Scopus
  30. D. D. Schramm and J. B. German, “Potential effects of flavonoids on the etiology of vascular disease,” The Journal of Nutritional Biochemistry, vol. 9, no. 10, pp. 560–566, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Galleano, V. Calabro, P. D. Prince et al., “Flavonoids and metabolic syndrome,” Annals of the New York Academy of Sciences, vol. 1259, no. 1, pp. 87–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Vinson, Y. A. Dabbagh, M. M. Serry, and J. Jang, “Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease,” Journal of Agricultural and Food Chemistry, vol. 43, no. 11, pp. 2800–2802, 1995. View at Google Scholar · View at Scopus
  33. P. C. H. Hollman, J. M. P. Van Trijp, M. N. C. P. Buysman et al., “Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man,” FEBS Letters, vol. 418, no. 1-2, pp. 152–156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Manach, A. Mazur, and A. Scalbert, “Polyphenols and prevention of cardiovascular diseases,” Current Opinion in Lipidology, vol. 16, no. 1, pp. 77–84, 2005. View at Google Scholar · View at Scopus
  35. R. Kleemann, L. Verschuren, M. Morrison et al., “Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models,” Atherosclerosis, vol. 218, no. 1, pp. 44–52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Koshy, L. Anila, and N. R. Vijayalakshmi, “Flavonoids from Garcinia cambogia lower lipid levels in hypercholesterolemic rats,” Food Chemistry, vol. 72, no. 3, pp. 289–294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Anila and N. R. Vijayalakshmi, “Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats,” Food Chemistry, vol. 83, no. 4, pp. 569–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zou, Y. Lu, and D. Wei, “Hypocholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet,” Journal of Agricultural and Food Chemistry, vol. 53, no. 7, pp. 2462–2466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. N. P. Visavadiya and A. V. R. L. Narasimhacharya, “Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 2, pp. 219–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Duarte, R. Pérez-Palencia, F. Vargas et al., “Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats,” British Journal of Pharmacology, vol. 133, no. 1, pp. 117–124, 2001. View at Google Scholar · View at Scopus
  41. M. F. Garciá-Saura, M. Galisteo, I. C. Villar et al., “Effects of chronic quercetin treatment in experimental renovascular hypertension,” Molecular and Cellular Biochemistry, vol. 270, no. 1-2, pp. 147–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Sánchez, M. Galisteo, R. Vera et al., “Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats,” Journal of Hypertension, vol. 24, no. 1, pp. 75–84, 2006. View at Google Scholar · View at Scopus
  43. A. Abbass, “Efficiency of some antioxidants in reducing cardio-metabolic risks in obese rats,” Journal of American Science, vol. 7, pp. 1146–1159, 2011. View at Google Scholar
  44. K.-H. Lee, E. Park, H.-J. Lee et al., “Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers,” Nutrition Research and Practice, vol. 5, no. 1, pp. 28–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. L. K. Stewart, J. L. Soileau, D. Ribnicky et al., “Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet,” Metabolism: Clinical and Experimental, vol. 57, no. 1, pp. S39–S46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Ohkoshi, H. Miyazaki, K. Shindo, H. Watanabe, A. Yoshida, and H. Yajima, “Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice,” Planta Medica, vol. 73, no. 12, pp. 1255–1259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Kobori, S. Masumoto, Y. Akimoto, and H. Oike, “Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice,” Molecular Nutrition and Food Research, vol. 55, no. 4, pp. 530–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Enkhmaa, K. Shiwaku, T. Katsube et al., “Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice,” Journal of Nutrition, vol. 135, no. 4, pp. 729–734, 2005. View at Google Scholar · View at Scopus
  49. P. M. Ridker, “C-reactive protein: a simple test to help predict risk of heart attack and stroke,” Circulation, vol. 108, no. 12, pp. e81–e85, 2003. View at Google Scholar · View at Scopus
  50. S. Bhaskar, K. S. Kumar, K. Krishnan, and H. Antony, “Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits,” Nutrition, vol. 29, no. 1, pp. 219–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Juźwiak, J. Wójcicki, K. Mokrzycki et al., “Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits,” Pharmacological Reports, vol. 57, no. 5, pp. 604–609, 2005. View at Google Scholar · View at Scopus
  52. S. Bhaskar, V. Shalini, and A. Helen, “Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway,” Immunobiology, vol. 216, no. 3, pp. 367–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. G. L. Hertog, P. C. H. Hollman, and B. Van de Putte, “Content of potentially anticareinogenic flavonoids of tea infusions, wines, and fruit juices,” Journal of Agricultural and Food Chemistry, vol. 41, no. 8, pp. 1242–1246, 1993. View at Google Scholar · View at Scopus
  54. K. H. Miean and S. Mohamed, “Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants,” Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3106–3112, 2001. View at Google Scholar · View at Scopus
  55. P. Siddhuraju and K. Becker, “Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves,” Journal of Agricultural and Food Chemistry, vol. 51, no. 8, pp. 2144–2155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Bajpai, A. Pande, S. K. Tewari, and D. Prakash, “Phenolic contents and antioxidant activity of some food and medicinal plants,” International Journal of Food Sciences and Nutrition, vol. 56, no. 4, pp. 287–291, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Chimenti, F. Cottiglia, L. Bonsignore et al., “Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study,” Journal of Natural Products, vol. 69, no. 6, pp. 945–949, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Silva, P. J. Oliveira, A. Dias, and J. O. Malva, “Quercetin, kaempferol and biapigenin from hypericum perforatum are neuroprotective against excitotoxic insults,” Neurotoxicity Research, vol. 13, no. 3-4, pp. 265–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Knekt, J. Kumpulainen, R. Järvinen et al., “Flavonoid intake and risk of chronic diseases,” American Journal of Clinical Nutrition, vol. 76, no. 3, pp. 560–568, 2002. View at Google Scholar · View at Scopus
  60. J. M. Calderon-Montano, E. Burgos-Morón, and M. López-Lázaro, “A review on the dietary flavonoid kaempferol,” Mini Review in Medicinal Chemistry, vol. 11, pp. 298–344, 2011. View at Google Scholar
  61. Y. C. Xu, D. K. Y. Yeung, R. Y. K. Man, and S. W. S. Leung, “Kaempferol enhances endothelium-independent and dependent relaxation in the porcine coronary artery,” Molecular and Cellular Biochemistry, vol. 287, no. 1-2, pp. 61–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H.-B. Xiao, X.-Y. Lu, X.-J. Chen, and Z.-L. Sun, “Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level,” European Journal of Pharmacology, vol. 616, no. 1-3, pp. 213–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Singh, B. Singh, S. Singh, N. Kumar, S. Kumar, and S. Arora, “Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del,” Toxicology in Vitro, vol. 22, no. 8, pp. 1965–1970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Kowalski, A. Samojedny, M. Paul, G. Pietsz, and T. Wilczok, “Effect of kaempferol on the production and gene expression of monocyte chemoattractant protein-1 in J774.2 macrophages,” Pharmacological Reports, vol. 57, no. 1, pp. 107–112, 2005. View at Google Scholar · View at Scopus
  65. L. Kong, C. Luo, X. Li, Y. Zhou, and H. He, “The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits,” Lipids in Health and Disease, vol. 12, no. 1, pp. 112–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. P. Chumark, P. Khunawat, Y. Sanvarinda et al., “The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 439–446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. M. G. Rajanandh, M. N. Satishkumar, K. Elango, and B. Suresh, “Moringa oleifera Lam. A herbal medicine for hyperlipidemia: a pre-clinical report,” Asian Pacific Journal of Tropical Disease, vol. 2, no. 2, pp. S790–S795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. X.-K. Fang, J. Gao, and D.-N. Zhu, “Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity,” Life Sciences, vol. 82, no. 11-12, pp. 615–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. M. R. Sulaiman, Z. A. Zakaria, I. A. Daud, F. N. Ng, Y. C. Ng, and M. T. Hidayat, “Antinociceptive and anti-inflammatory activities of the aqueous extract of Kaempferia galanga leaves in animal models,” Journal of Natural Medicines, vol. 62, no. 2, pp. 221–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. J. M. Harnly, R. F. Doherty, G. R. Beecher et al., “Flavonoid content of U.S. fruits, vegetables, and nuts,” Journal of Agricultural and Food Chemistry, vol. 54, no. 26, pp. 9966–9977, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. A. M. Gray and P. R. Flatt, “Nature's own pharmacy: the diabetes perspective,” Proceedings of the Nutrition Society, vol. 56, no. 1999, pp. 507–517, 1997. View at Google Scholar · View at Scopus
  72. L. Mira, M. T. Fernandez, M. Santos, R. Rocha, M. H. Florêncio, and K. R. Jennings, “Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity,” Free Radical Research, vol. 36, no. 11, pp. 1199–1208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. T. P. T. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Shimmyo, T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto, “Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3,” Journal of Neuroscience Research, vol. 86, no. 8, pp. 1836–1845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. N. J. Kang, S. K. Jung, K. W. Lee, and H. J. Lee, “Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis,” Annals of the New York Academy of Sciences, vol. 1229, no. 1, pp. 124–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Li and Y. Ding, “Minireview: therapeutic potential of myricetin in diabetes mellitus,” Food Science and Human Wellness, vol. 1, pp. 19–25, 2012. View at Google Scholar
  77. S. Godse, M. Mohan, V. Kasture, and S. Kasture, “Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensive rats,” Pharmaceutical Biology, vol. 48, no. 5, pp. 494–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. C. J. Chang, T.-F. Tzeng, S.-S. Liou, Y.-S. Chang, and I.-M. Liu, “Myricetin increases hepatic peroxisome proliferator-activated receptor protein expression and decreases plasma lipids and adiposity in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 787152, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. D. T. Ha, P. T. Thuang, and N. D. Thuan, “Protective action of Ampelopsis cantoniensis and its major constituent—myricetin against LDL oxidation,” Journal of Chemistry, vol. 45, pp. 768–771, 2007. View at Google Scholar
  80. T.-W. Lian, L. Wang, Y.-H. Lo, I.-J. Huang, and M.-J. Wu, “Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages,” Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, vol. 1781, no. 10, pp. 601–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. B. D. Paul, G. S. Rao, and G. J. Kapadia, “Isolation of myricadiol, myricitrin, taraxerol, and taraxerone from Myrica cerifera L. root bark,” Journal of Pharmaceutical Sciences, vol. 63, no. 6, pp. 958–959, 1974. View at Google Scholar · View at Scopus
  82. W. L. R. Barbosa, A. Peres, S. Gallori et al., “Determination of myricetin derivatives in Chrysobalanus icaco L., (Chrysobalanaceae),” Brazilian Journal of Pharmacognosy, vol. 16, pp. 333–337, 2006. View at Google Scholar
  83. S. Kreft, M. Knapp, and I. Kreft, “Extraction of rutin from buckwheat (Fagopyrum esculentum moench) seeds and determination by capillary electrophoresis,” Journal of Agricultural and Food Chemistry, vol. 47, no. 11, pp. 4649–4652, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Metodiewa, A. Kochman, and S. Karolczak, “Evidence for antiradical and antioxidant properties of four biologically active N,N-diethylamioethyl ethers of flavanone oximes: a comparison with natural polyphenolic flavonoid (rutin) action,” International Union of Biochemistry and Molecular Life, vol. 41, no. 5, pp. 1067–1075, 1997. View at Google Scholar · View at Scopus
  85. S. A. Aherne and N. M. O'Brien, “Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells,” Nutrition and Cancer, vol. 34, no. 2, pp. 160–166, 1999. View at Google Scholar · View at Scopus
  86. T. Guardia, A. E. Rotelli, A. O. Juarez, and L. E. Pelzer, “Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat,” Farmaco, vol. 56, no. 9, pp. 683–687, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. H. J. Chan, Y. L. Ji, H. C. Chul, and J. K. Chang, “Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin,” Archives of Pharmacal Research, vol. 30, no. 12, pp. 1599–1607, 2007. View at Google Scholar · View at Scopus
  88. G. B. Reddy, P. Muthenna, C. Akileshwari, M. Saraswat, and J. M. Petrash, “Inhibition of aldose reductase and sorbitol accumulation by dietary rutin,” Current Science, vol. 101, no. 9, pp. 1191–1197, 2011. View at Google Scholar · View at Scopus
  89. W. K. Dae, K. H. In, S. L. Soon et al., “Germinated buckwheat extract decreases blood pressure and nitrotyrosine immunoreactivity in aortic endothelial cells in spontaneously hypertensive rats,” Phytotherapy Research, vol. 23, no. 7, pp. 993–998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. C.-L. Hsu, C.-H. Wu, S.-L. Huang, and G.-C. Yen, “Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats,” Journal of Agricultural and Food Chemistry, vol. 57, no. 2, pp. 425–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. O. N. Voskresensky and V. N. Bobyrev, “Effect of ascorbic acid and rutin on the development of experimental peroxide atherosclerosis,” Farmakologiyai Toksikologiya, vol. 42, no. 4, pp. 378–382, 1979. View at Google Scholar · View at Scopus
  92. K. F. R. Santos, T. T. Oliveira, T. J. Nagem, A. S. Pinto, and M. G. A. Oliveira, “Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations,” Pharmacological Research, vol. 40, no. 6, pp. 493–496, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Kanashiro, D. C. O. andrade, L. M. Kabeya et al., “Modulatory effects of rutin on biochemical and hematological parameters in hypercholesterolemic Golden Syrian hamsters,” Annals of the Brazilian Academy of Sciences, vol. 81, no. 1, pp. 67–71, 2009. View at Google Scholar · View at Scopus
  94. B. Buszewski, S. Kawka, Z. Suprynowicz, and T. Wolski, “Simultaneous isolation of Rutin and Esculin from plant material and drugs using solid-phase extraction,” Journal of Pharmaceutical and Biomedical Analysis, vol. 11, no. 3, pp. 211–215, 1993. View at Publisher · View at Google Scholar · View at Scopus
  95. D. J. Afshar and A. Delazar, “Rutin from Ruta graveolens L.,” DARU Journal of Pharmaceutical Sciences, vol. 4, pp. 1–12, 1994. View at Google Scholar
  96. M. Atanassova and V. Bagdassarian, “Rutin in plant products,” Journal of the University of Chemical Technology and Metallurgy, vol. 44, pp. 201–203, 2009. View at Google Scholar
  97. P. Shukla, B. Gopalkrishna, and P. Shukla, “Isolation of rutin from Phyllanthus amarus,” International Journal of Pharmaceutical Sciences and Research, vol. 3, pp. 1198–1201, 2012. View at Google Scholar
  98. S.-M. Jeon, S.-H. Bok, M.-K. Jang et al., “Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits,” Clinica Chimica Acta, vol. 317, no. 1-2, pp. 181–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. F. A. A. Van Acker, O. Schouten, G. R. M. M. Haenen, W. J. F. Van Der Vijgh, and A. Bast, “Flavonoids can replace α-tocopherol as an antioxidant,” FEBS Letters, vol. 473, no. 2, pp. 145–148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. N. M. Borradaile, K. K. Carroll, and E. M. Kurowska, “Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin,” Lipids, vol. 34, no. 6, pp. 591–598, 1999. View at Publisher · View at Google Scholar · View at Scopus
  101. S.-H. Lee, T.-S. Jeong, Y. B. Park, Y.-K. Kwon, M.-S. Choi, and S.-H. Bok, “Hypocholesterolemic effect of hesperetin mediated by inhibition of 3- hydroxy-3-methylgultaryl coenzyme A reductase and acyl coenzyme A: cholesterol acyltransferase in rats fed high-cholesterol diet,” Nutrition Research, vol. 19, no. 8, pp. 1245–1258, 1999. View at Publisher · View at Google Scholar · View at Scopus
  102. S. H. Lee, Y. B. Park, K. H. Bae et al., “Cholesterol-lowering activity of naringenin via inhibition of 8-hydroxy-3-methylglutaryl coenzyme a reductase and acyl coenzyme A: cholesterol acyltransferase in rats,” Annals of Nutrition and Metabolism, vol. 43, no. 3, pp. 173–180, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. E. M. Kurowska, N. M. Borradaile, J. D. Spence, and K. K. Carroll, “Hypocholesterolemic effects of dietary citrus juices in rabbits,” Nutrition Research, vol. 20, no. 1, pp. 121–129, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. E. M. Kurowska, J. D. Spence, J. Jordan et al., “HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia,” American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1095–1100, 2000. View at Google Scholar · View at Scopus
  105. J.-J. Lee, H. Yi, I.-S. Kim et al., “(2S)-Naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest,” Journal of Ethnopharmacology, vol. 139, pp. 873–878, 2012. View at Google Scholar
  106. E. E. Mulvihill, J. M. Assini, B. G. Sutherland et al., “Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 742–748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. M. F. Ruh, T. Zacharewski, K. Connor, J. Howell, I. Chen, and S. Safe, “Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity,” Biochemical Pharmacology, vol. 50, no. 9, pp. 1485–1493, 1995. View at Publisher · View at Google Scholar · View at Scopus
  108. G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson et al., “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β,” Endocrinology, vol. 139, no. 10, pp. 4252–4263, 1998. View at Google Scholar · View at Scopus
  109. R. S. Rosenberg, L. Grass, D. J. A. Jenkins, C. W. C. Kendall, and E. P. Diamandis, “Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines,” Biochemical and Biophysical Research Communications, vol. 248, no. 3, pp. 935–939, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. H. Déchaud, C. Ravard, F. Claustrat, A. B. De La Perrière, and M. Pugeat, “Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG),” Steroids, vol. 64, no. 5, pp. 328–334, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. J. A. Manthey, N. Guthrie, and K. Grohmann, “Biological properties of citrus flavonoids pertaining to cancer and inflammation,” Current Medicinal Chemistry, vol. 8, no. 2, pp. 135–153, 2001. View at Google Scholar · View at Scopus
  112. K. Yoon, L. Pallaroni, M. Stoner, K. Gaido, and S. Safe, “Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements,” Journal of Steroid Biochemistry and Molecular Biology, vol. 78, no. 1, pp. 25–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Krause and R. Galensa, “Determination of naringenin and naringenin-chalcone in tomato skins by reversed phase HPLC after solid phase extraction,” Zeitschrift für Lebensmittel-Untersuchung und -Forschung, vol. 194, no. 1, pp. 29–32, 1992. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, and M. Yano, “Quantitation of flavonoid constituents in Citrus fruits,” Journal of Agricultural and Food Chemistry, vol. 47, no. 9, pp. 3565–3571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  115. H. T. Olsen, G. I. Stafford, J. van Staden, S. B. Christensen, and A. K. Jäger, “Isolation of the MAO-inhibitor naringenin from Mentha aquatica L.,” Journal of Ethnopharmacology, vol. 117, no. 3, pp. 500–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. L. Liu, S. Shan, K. Zhang, Z.-Q. Ning, X.-P. Lu, and Y.-Y. Cheng, “Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin,” Phytotherapy Research, vol. 22, no. 10, pp. 1400–1403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. C. A. de Andrade, J. L. D. S. Carvalho, M. M. Cunico et al., “Antioxidant and antibacterial activity of extracts, fractions and isolated substances from the flowers of Acacia podalyriifolia A. Cunn. ex G. Don,” Brazilian Journal of Pharmaceutical Sciences, vol. 46, no. 4, pp. 715–721, 2010. View at Google Scholar · View at Scopus
  118. K. Yoshino, Y. Hara, M. Sano, and I. Tomita, “Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of liver homogenates induced by tert-butyl hydroperoxide,” Biological and Pharmaceutical Bulletin, vol. 17, no. 1, pp. 146–149, 1994. View at Google Scholar · View at Scopus
  119. N. Salah, N. J. Miller, G. Paganga, L. Tijburg, G. P. Bolwell, and C. Rice-Evans, “Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants,” Archives of Biochemistry and Biophysics, vol. 322, no. 2, pp. 339–346, 1995. View at Publisher · View at Google Scholar · View at Scopus
  120. K. F. Gey, “Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk,” Journal of Nutritional Biochemistry, vol. 6, no. 4, pp. 206–236, 1995. View at Publisher · View at Google Scholar · View at Scopus
  121. J. A. Vita, “Tea consumption and cardiovascular disease: effects on endothelial function,” Journal of Nutrition, vol. 133, no. 10, pp. 3293s–3297s, 2003. View at Google Scholar · View at Scopus
  122. V. Stangl, M. Lorenz, and K. Stangl, “The role of tea and tea flavonoids in cardiovascular health,” Molecular Nutrition and Food Research, vol. 50, no. 2, pp. 218–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Stangl, H. Dreger, K. Stangl, and M. Lorenz, “Molecular targets of tea polyphenols in the cardiovascular system,” Cardiovascular Research, vol. 73, no. 2, pp. 348–358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. S. M. Shenouda and J. A. Vita, “Effects of flavonoid-containing beverages and EGCG on endothelial function,” Journal of the American College of Nutrition, vol. 26, no. 4, pp. 366s–372s, 2007. View at Google Scholar · View at Scopus
  125. N. Khan and H. Mukhtar, “Tea polyphenols for health promotion,” Life Sciences, vol. 81, no. 7, pp. 519–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. H. Y. Ahn, Y. Xu, and S. T. Davidge, “Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cells,” Life Sciences, vol. 82, no. 17-18, pp. 964–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Furuyashiki, H. Nagayasu, Y. Aoki et al., “Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells,” Bioscience, Biotechnology and Biochemistry, vol. 68, no. 11, pp. 2353–2359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. M. A. Potenza, F. L. Marasciulo, M. Tarquinio et al., “EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR,” American Journal of Physiology: Endocrinology and Metabolism, vol. 292, no. 5, pp. E1378–E1387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. C. A. Bursill and P. D. Roach, “A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats,” Lipids, vol. 42, no. 7, pp. 621–627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. M. E. Widlansky, N. M. Hamburg, E. Anter et al., “Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease,” Journal of the American College of Nutrition, vol. 26, no. 2, pp. 95–102, 2007. View at Google Scholar · View at Scopus
  131. V. Ossipov, K. Nurmi, J. Loponen, E. Haukioja, and K. Pihlaja, “High-performance liquid chromatographic separation and identification of phenolic compounds from leaves of Betula pubescens and Betula pendula,” Journal of Chromatography A, vol. 721, no. 1, pp. 59–68, 1996. View at Publisher · View at Google Scholar · View at Scopus
  132. C. Kirszberg, D. Esquenazi, C. S. Alviano, and V. M. Rumjanek, “The effect of a catechin-rich extract of Cocos nucifera on lymphocytes proliferation,” Phytotherapy Research, vol. 17, no. 9, pp. 1054–1058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. Z. Charrouf and D. Guillaume, “Phenols and polyphenols from Argania spinosa,” American Journal of Food Technology, vol. 2, no. 7, pp. 679–683, 2007. View at Google Scholar · View at Scopus
  134. P. Daisy, K. Balasubramanian, M. Rajalakshmi, J. Eliza, and J. Selvaraj, “Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats,” Phytomedicine, vol. 17, no. 1, pp. 28–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Arai, S. Watanabe, M. Kimira, K. Shimoi, R. Mochizuki, and N. Kinae, “Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration,” Journal of Nutrition, vol. 130, no. 9, pp. 2243–2250, 2000. View at Google Scholar · View at Scopus
  136. R. P. Constantin, J. Constantin, C. L. S. Pagadigorria et al., “Prooxidant activity of fisetin: effects on energy metabolism in the rat liver,” Journal of Biochemical and Molecular Toxicology, vol. 25, no. 2, pp. 117–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. F. Y. Goh, N. Upton, S. Guan et al., “Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB,” European Journal of Pharmacology, vol. 679, no. 1-3, pp. 109–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. P.-M. Yang, H.-H. Tseng, C.-W. Peng, W.-S. Chen, and S.-J. Chiu, “Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy,” International Journal of Oncology, vol. 40, no. 2, pp. 469–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  139. N. Khan, F. Afaq, D. N. Syed, and H. Mukhtar, “Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells,” Carcinogenesis, vol. 29, no. 5, pp. 1049–1056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. G. S. Prasath and S. P. Subramanian, “Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats,” European Journal of Pharmacology, vol. 668, no. 3, pp. 492–496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. Y. Lee and E. J. Bae, “Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells,” Archives of Pharmacal Research, vol. 36, pp. 1377–1384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  142. C. H. Jung, H. Kim, J. Ahn, T.-I. Jeon, D.-H. Lee, and T.-Y. Ha, “Fisetin regulates obesity by targeting mTORC1 signaling,” The Journal of Nutritional Biochemistry, vol. 24, no. 8, pp. 1547–1554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  143. J. Reed, “Cranberry flavonoids, atherosclerosis and cardiovascular health,” Critical Reviews in Food Science and Nutrition, vol. 42, no. 3, pp. 301–316, 2002. View at Google Scholar · View at Scopus
  144. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum, “Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,” The New England Journal of Medicine, vol. 320, no. 14, pp. 915–924, 1989. View at Google Scholar · View at Scopus
  145. C. V. De Whalley, S. M. Rankin, J. R. S. Hoult, W. Jessup, and D. S. Leake, “Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages,” Biochemical Pharmacology, vol. 39, no. 11, pp. 1743–1750, 1990. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Gábor and E. Eperjessy, “Antibacterial effect of fisetin and fisetinidin,” Nature, vol. 212, no. 5067, p. 1273, 1966. View at Publisher · View at Google Scholar · View at Scopus
  147. J. Lako, V. C. Trenerry, M. Wahlqvist, N. Wattanapenpaiboon, S. Sotheeswaran, and R. Premier, “Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods,” Food Chemistry, vol. 101, no. 4, pp. 1727–1741, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. J.-D. Lee, J.-E. Huh, G. Jeon et al., “Flavonol-rich RVHxR from Rhus verniciflua stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models,” International Immunopharmacology, vol. 9, no. 3, pp. 268–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. T. D. A. Forbes and B. A. Clement, “Chemistry of Acacia's from South Texas,” Texas A&M Agricultural Research and Extension Center, pp. 4–14, 2010. View at Google Scholar
  150. H.-H. Lin, J.-H. Chen, and C.-J. Wang, “Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa linne,” Current Medicinal Chemistry, vol. 18, no. 8, pp. 1245–1254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. J. H. Chen, C. W. Tsai, C. P. Wang, and H. H. Lin, “Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation,” Toxicology and Applied Pharmacology, vol. 272, pp. 313–324, 2013. View at Google Scholar
  152. J. B. Harborne, “Gossypetin and herbacetin as taxonomic markers in higher plants,” Phytochemistry, vol. 8, no. 1, pp. 177–183, 1969. View at Google Scholar · View at Scopus
  153. G. Bendz, Chemistry in Botanical Classification: Medicine and Natural Sciences, Science, 2013.
  154. S. M. Rankin, C. V. De Whalley, J. R. S. Hoult et al., “The modification of low density lipoprotein by the flavonoids myricetin and gossypetin,” Biochemical Pharmacology, vol. 45, no. 1, pp. 67–75, 1993. View at Publisher · View at Google Scholar · View at Scopus
  155. H. Mozaffari-Khosravi, B.-A. Jalali-Khanabadi, M. Afkhami-Ardekani, F. Fatehi, and M. Noori-Shadkam, “The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes,” Journal of Human Hypertension, vol. 23, no. 1, pp. 48–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. E. V. Villalpando-Arteaga, E. Mendieta-Condado, H. Esquivel-Solís et al., “Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice,” Food & Function, vol. 4, pp. 618–626, 2013. View at Google Scholar